sCAUTION – Investigational device. Limited by U.S. Federal law to investigational use under early feasibility study (EFS) and by foreign regulatory agencies for clinical assay in respective countries.

NaviGate Cardiac Structures, Inc.
  • Home
  • About
  • Technology
  • Tricuspid Regurgitation
  • News & Events
  • Contact
Select Page

Quebec University in Laval, Canada. This is the first tricuspid valve replacement in Canada.

Press Release

Communiqué de presse PREMIÈRE MÉDICALE CANADIENNE : UN 10E CAS DE REMPLACEMENT TRICUSPIDE PERCUTANÉ AU MONDE RÉALISÉ À L’INSTITUT Québec, 8 février 2018 – L’Institut universitaire de cardiologie et de pneumologie de Québec– Université Laval (l’Institut) a récemment...

Recent Posts

  • iVascular SLU, Barcelona Invests in NaviGate Cardiac Structures, Inc.
  • Quebec University in Laval, Canada. This is the first tricuspid valve replacement in Canada.
  • NaviGate Cardiac Structures, Inc., presents data of studies on the Gate™ valved stent for correction of Functional Tricuspid Regurgitation at Paris PCR2016.

Upcoming Events

  • Euro PCR – Palais des Congrès – Paris, FranceMay 1, 2019
  • PCR London Valves, European Association of Percutaneous Cardiovascular InterventionsSeptember 2, 2019
  • Transcatheter Cardiovascular Therapeutics (TCT), Cardiovascular Research FoundationSeptember 23, 2019

Topics

  • Announcement
  • Press Release
logo

Tricuspid Regurgitation, TR, FTR, Valve Replacement, Novel Solution, Unmet Clinical Need, Ignored Valve, Forgotten Valve

Browse

  • Home
  • About
  • Technology
  • Tricuspid Regurgitation
  • News & Events
  • Investors
  • Contact
Have Questions?

Do you have questions about the NaviGate™ System? Please let us know!

Send us an email

© 2019 NaviGate Cardiac Structures, Inc. - All Rights Reserved. Terms and Conditions | Privacy Policy | Website and Design by SDA Creative